GENE ONLINE|News &
Opinion
Blog

Crohn’s disease
The First and Only FDA-approved Drug for Chronic Digestive Diseases by Celltrion USA
2023-10-25
Merck Buys Prometheus For $10.8 Billion, Lands Promising Autoimmune Asset
2023-04-17
Applications for Medicine Treating Crohn’s Disease Submitted to EMA and FDA
2022-07-29
AbbVie Scores First FDA Thumbs Up for Crohn’s Disease
2022-06-20
R&D
Lilly’s Investigational Monoclonal Antibody Registers Symptom Improvement in Crohn’s Disease Patients
2020-10-13
Spotlight: Celltrion Healthcare’s Remsima Expands to Multiple Medical Uses
2020-07-20
Finch’s First Microbial Cocktail Treating Clostridium Infection Registers Positive Results
2020-06-24
AbbVie Completes Acquisition of Botox Manufacturer, Allergan
2020-05-11
Kangstem Biotech Rethinks Strategy with New Stem Cell Drug against Atopic Dermatitis
2020-03-04
Weekly in Asia(0428-0503)
2019-05-09
LATEST
Company Presentations at BIO 2024 Inspire Partnering
2024-06-14
GV Regains Compliance with Nasdaq Minimum Bid Price Requirement
2024-06-13
ARPA-H Fast-Tracks Biotech Startups: Funding Insights from BIO 2024 Panel
2024-06-12
Gene Therapy Innovations and Financial Challenges for the Future of Medicine
2024-06-12
BIO Releases DEI Survey in Partnership with Korn Ferry
2024-06-11
Advancing Healthcare Accessibility and Sustainable Development
2024-06-11
New CRISPR Method Enables Gene Edits in Cockroaches and All Insects
2024-06-11
EVENT
Scroll to Top